{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15116294",
  "DateCompleted": {
    "Year": "2004",
    "Month": "06",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "02",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2004",
        "Month": "04",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-1899",
      "JournalIssue": {
        "Volume": "189",
        "Issue": "9",
        "PubDate": {
          "Year": "2004",
          "Month": "May",
          "Day": "01"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.",
    "Pagination": {
      "StartPage": "1590",
      "EndPage": "1597",
      "MedlinePgn": "1590-7"
    },
    "Abstract": {
      "AbstractText": [
        "Our objective was to prospectively determine the factors influencing the probability of a good microbiological or clinical outcome in patients with nosocomial pneumonia treated with a fluoroquinolone. Levofloxacin was administered as an infusion of 500 mg/h for 1.5 h (total dose, 750 mg). For patients with Pseudomonas aeruginosa or methicillin-resistant Staphylococcus aureus, a second drug was added (ceftazidime or piperacillin/tazobactam for P. aeruginosa and vancomycin for methicillin-resistant S. aureus). Population pharmacokinetic studies of 58 patients demonstrated that this population handled the drug differently from populations of volunteers. Multivariate logistic regression analysis (n=47 patients) demonstrated that only the age of the patient and the achievement of an area under the curve: minimum inhibitory concentration ratio of > or =87 had a significant effect on eradication of the pathogen (P<.001). Achieving the breakpoint made the patient 4 times more likely to achieve eradication. The effect was greatest in patients > or =67 years old."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Ordway Research Institute, Albany, New York 12208, USA. gldrusano@aol.com."
          }
        ],
        "LastName": "Drusano",
        "ForeName": "George L",
        "Initials": "GL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Preston",
        "ForeName": "Sandra L",
        "Initials": "SL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fowler",
        "ForeName": "Cynthia",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Corrado",
        "ForeName": "Michael",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Weisinger",
        "ForeName": "Barbara",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kahn",
        "ForeName": "James",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "Journal Article",
      "Randomized Controlled Trial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Fluoroquinolones"
    },
    {
      "RegistryNumber": "6GNT3Y5LMF",
      "NameOfSubstance": "Levofloxacin"
    },
    {
      "RegistryNumber": "A4P49JAZ9H",
      "NameOfSubstance": "Ofloxacin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacokinetics",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Area Under Curve"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacokinetics",
        "therapeutic use"
      ],
      "DescriptorName": "Fluoroquinolones"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Levofloxacin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Methicillin Resistance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacokinetics",
        "therapeutic use"
      ],
      "DescriptorName": "Ofloxacin"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Pneumonia, Bacterial"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Pneumonia, Staphylococcal"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Pseudomonas Infections"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Pseudomonas aeruginosa"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Staphylococcus aureus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}